Menu
MorphoSys US

Investor & Media information

You are here

  1. Home
  2. Media and investors
  3. Investor & Media information

MorphoSys is strictly committed to the principle of fair disclosure. One of the most important foundations of our corporate communication is to inform all stakeholders simultaneously and comprehensively about the situation of the Company. We pay great attention to transparent and timely communication.

Corporate media releases

Date
Title

2020

  1. 02/03/2020
    FDA Accepts MorphoSys' Biologics License Application (BLA) and Grants Priority Review for Tafasitamab and Lenalidomide for the Treatment of Relapsed/Refractory DLBCL
  2. 04/02/2020
    MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.
  3. 13/01/2020
    MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab
  4. 13/01/2020
    MorphoSys AG: Ad hoc: MorphoSys and Incyte Sign Global Collaboration and License Agreement, including U.S. Co-Commercialization and Ex-U.S. Commercialization Rights, for Tafasitamab
    No download available

2019

  1. 30/12/2019
    MorphoSys Announces Submission of Biologics License Application for Tafasitamab in r/r DLBCL to the FDA
  2. 27/12/2019
    First Patient Dosed in Phase 1 Clinical Study of Tafasitamab in Firstline DLBCL
  3. 12/12/2019
    MorphoSys AG: Corporate Calendar 2020
  4. 20/11/2019
    Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure
  5. 18/11/2019
    MorphoSys' tafasitamab B-MIND DLBCL study successfully passed futility analysis
  6. 15/11/2019
    MorphoSys Continues to Build Commercial Presence by Opening new U.S. Headoffice

Pages

Order form for publications and reports

Ad-hoc releases

Sorry, but there are no ad-hoc releases available for the selected year.

Pages

Conferences

Wednesday, January 13, 2021
Webcast: 39th Annual J.P. Morgan Healthcare Conference

Dr. Jean-Paul Kress presents the Company at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at 02:50pm ET (08:50pm CET).
Go to Webcast...

DocumentFile info
JPM Presentation 2021_MorphoSys3.01 MB

Archive

Date
Title
MP3

2021

  1. 01/13/2021

    Webcast: 39th Annual J.P. Morgan Healthcare Conference

2020

  1. 12/16/2020

    Webcast: JMP Securities Hematology Summit

  2. 11/17/2020

    Stifel 2020 Virtual HC Conference

  3. 11/12/2020

    Conference Call and Webcast: Q3/9M 2020 Financial Results

  4. 09/29/2020

    Conference Call and Webcast: MorphoSys & Incyte Tafasitamab Expert Event

  5. 08/06/2020

    Conference Call and Webcast: Q2/H1 2020 Financial Results

  6. 08/03/2020

    Joint MorphoSys and Incyte Conference Call

  7. 06/18/2020

    Webcast: JMP Securities Hematology and Oncology Forum

  8. 06/10/2020

    Webcast: Goldman Sachs 41st Annual Global Healthcare Conference

  9. 06/03/2020

    Webcast: Jefferies 2020 Healthcare Conference

  10. 05/07/2020

    Conference Call and Webcast: Q1 2020 Financial Results

  11. 03/19/2020

    Conference Call and Webcast: Year End 2019

  12. 02/26/2020

    Webcast: 9th Annual SVB Leerink Global Healthcare Conference

  13. 01/15/2020

    Webcast: 38th Annual J.P. Morgan Healthcare Conference

Pages

Company Update

Date
Venue
Download

2020

  1. 01/13/2021
    Company Update

Pictures

Technology

Ylanthia

Ylanthia technology

Slonomics

Slonomics technology

HuCAL

HuCAL antibody library

HuCAL

Scientist working with the HuCAL library

Lab shots

Antibody purification

Scientist in protein chemistry lab

Daily work

MorphoSys scientist working in laboratory

Scientist with petri dishes

MorphoSys scientist handling petri dishes

Cell culture experiment

MorphoSys scientist in cell culture lab

Miscellaneous

MorphoSys Building Planegg

View of the Building of MorphoSys in Planegg/Munich, Germany

MorphoSys Building Planegg

Entrance of the Building of MorphoSys in Planegg/Munich, Germany

MorphoSys Logo
MorphoSys Footage Video

Copyright notice: The photos provided for download on this website can be used free of charge in the context of editorial reporting with the indication of the photo credit "©MorphoSys AG".

 

You are leaving morphosys.com and will be transferred to the MorphoSys US website which is intended for US residents.

Do you wish to proceed?

Yes No